These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 4299859

  • 1. Hypocalcemic effect of imidazole in rats.
    Wells H, Lloyd W.
    Endocrinology; 1968 Sep; 83(3):521-9. PubMed ID: 4299859
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of the hypocalcemic action of thyrocalcitonin by theophylline and isoproterenol.
    Wells H, Lloyd W.
    Endocrinology; 1968 Mar; 82(3):468-74. PubMed ID: 5641540
    [No Abstract] [Full Text] [Related]

  • 4. Protamine-induced hypocalcemia.
    Johnston CC, Grinnan EL, Wilson HC, Boder GB.
    Endocrinology; 1970 Dec; 87(6):1211-7. PubMed ID: 4320597
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modification by cortisone of the plasma Ca and P responses to imidazole and theophylline.
    Bird PC, Palmieri GM, Eliel LP.
    Endocrinology; 1971 May; 88(5):1267-71. PubMed ID: 4323119
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of the hypercalcemic action of vitamin D 3 with imidazole.
    Avery SH, Bell NH, Stern PH.
    Endocrinology; 1971 Oct; 89(4):951-7. PubMed ID: 4328498
    [No Abstract] [Full Text] [Related]

  • 9. Cyclic 3',5'-adenylic acid in bone and the mechanism of action of parathyroid hormone. Discussion.
    Wells H, Lloyd W.
    Fed Proc; 1970 Oct; 29(3):1183-4. PubMed ID: 4315366
    [No Abstract] [Full Text] [Related]

  • 10. 2-Thiophenecarboxylic acid: a hypoglycemic, antilipolytic agent with hypocalcemic and hypophosphatemic effects in rats.
    Lloyd W, Fang VS, Wells H, Tashjian AH.
    Endocrinology; 1969 Oct; 85(4):763-8. PubMed ID: 4308480
    [No Abstract] [Full Text] [Related]

  • 11. Role of glucagon and adrenergic receptors in thyrocalcitonin release in the dog.
    Avioli LV, Shieber W, Kipnis DM.
    Endocrinology; 1971 Jun; 88(6):1337-40. PubMed ID: 4324677
    [No Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone and thyrocalcitonin function in cortisol-treated rats.
    Talmage RV, Park HZ, Jee W.
    Endocrinology; 1970 May; 86(5):1080-4. PubMed ID: 5435249
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of dibutyryl cyclic adenosine 3',5'-monophosphate, theophylline, and other nucleotides upon calcium and phosphate metabolism.
    Rasmussen H, Pechet M, Fast D.
    J Clin Invest; 1968 Aug; 47(8):1843-50. PubMed ID: 4299012
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [On the hypocalcemic effect of endogenous and exogenous thyrocalcitonin in the rat].
    Ziegler R, Riechmann K, Grebenstein R, Pfeiffer EF.
    Klin Wochenschr; 1968 Jun 01; 46(11):587-93. PubMed ID: 5726585
    [No Abstract] [Full Text] [Related]

  • 20. Thyrocalcitonin and its role in calcium regulation in mammals.
    Hirsch PF.
    J Exp Zool; 1971 Sep 01; 178(1):139-49. PubMed ID: 4937553
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.